Industry Overview

UK medical device technology market was valued at $19.9 billion in 2025 and is projected to reach $31.3 billion by 2035, growing at a CAGR of 4.7% during the forecast period (2026–2035). The UK medical device technology market is experiencing steady growth, driven by the modernization of healthcare infrastructure, rising demand for advanced diagnostic and therapeutic solutions, and the increasing prevalence of chronic diseases. Hospitals and specialty centers are investing in high-precision imaging systems, automated laboratory equipment, and minimally invasive devices to enhance patient outcomes. Government initiatives supporting innovation, faster regulatory approvals, and the adoption of digital health technologies are further accelerating market expansion. Collaborations between domestic and international manufacturers are enabling the introduction of next-generation devices across various clinical settings.

Market Dynamics

Focus on Digital Diagnostics

The UK is seeing strong adoption of digital diagnostic solutions, including AI-assisted imaging, automated laboratory analyzers, and point-of-care testing platforms. This is driven by the need for faster and more accurate disease detection and management. Key players such as Roche, Abbott, and Siemens Healthineers are expanding their offerings with advanced, integrated diagnostic tools. Recent trends highlight increased integration of cloud-based reporting and remote monitoring to streamline clinical workflows and improve patient care.

Growth in Minimally Invasive and Specialty Devices

Minimally invasive devices are gaining traction in cardiology, orthopedics, and ophthalmology as healthcare providers prioritize reduced recovery times and improved procedural outcomes. Hospitals are adopting robotic-assisted systems, image-guided tools, and precision implants to support complex procedures. Leading companies, including Medtronic, Boston Scientific, and Stryker, are introducing scalable and efficient solutions suitable for UK healthcare settings. Recent developments also include partnerships between manufacturers and NHS facilities to optimize device performance and accessibility.

Market Segmentation

• Based on the device type, the market is segmented into in vitro diagnostics devices, diagnostic imaging devices, cardiology devices, ophthalmology devices, orthopedic devices, and others.

In Vitro Diagnostics Devices Segment to Lead the Market with the Largest Share

The IVD segment in the UK is expanding due to higher demand for automated laboratory systems, molecular testing platforms, and point-of-care solutions. Rising chronic disease prevalence, aging population, and government support for laboratory modernization are driving growth. Companies such as Roche, Abbott, and Siemens Healthineers are introducing innovative solutions that improve speed, accuracy, and workflow efficiency. Digital integration and AI-based interpretation are increasingly being adopted to enhance diagnostic decision-making.

Diagnostic Imaging Devices: A Key Segment in Market Growth

Diagnostic imaging remains a key growth area in the UK, supported by investments in advanced MRI, CT, ultrasound, and digital X-ray systems. Hospitals and specialty centers are upgrading equipment to ensure precise diagnostics and faster results. The prominent market players, including GE HealthCare, Philips, and Canon Medical, are offering energy-efficient, compact, and AI-enhanced imaging solutions. Cloud-based storage, remote reading, and AI-assisted analysis are increasingly used to optimize workflow and diagnostic accuracy.

Market Players Outlook

The major companies operating in the UK medical device technology market include Medtronic plc, Siemens Healthineers, GE Healthcare, Abbott Laboratories, and B. Braun Melsungen SE, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In June 2024, Royal Philips showcased the first mobile virtually helium-free MRI system, marking a significant step as an innovator to improve patient access to diagnostic technology whilst caring for the environment. This significantly reduces consumption of helium, which globally is in scarce supply. More than 1.9 million liters of helium have been saved by MR systems equipped with Philips’ BlueSeal magnet technology since 2018.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the UK medical device technology market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.